Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
M. Henry's research focuses on cardiovascular health, particularly in the context of structural heart disease interventions and pediatric critical care. Recent publications include an evaluation of transcatheter aortic valve replacement techniques and an analysis of exclusion rates for transcatheter mitral and tricuspid valve structural heart clinical trials. Henry also investigates prognostic tools for predicting brain death following out-of-hospital cardiac arrest in children and has published on point-of-care ultrasound in pediatrics. Additionally, Henry has explored the detection of SARS-CoV-2 antibodies in human milk and their persistence six months after maternal vaccination, as well as the role of CMV promoter methylation in cell productivity for recombinant monoclonal antibody production. With 91 publications and an h-index of 16, Henry's work contributes to advancements in cardiac interventions, pediatric emergency medicine, and immunology.
Metrics
- h-index: 16
- Publications: 91
- Citations: 1,048
Selected Publications
-
Study protocol for a pilot study for Remote ADHD Monitoring Program (RAMP) for children in rural areas (2025)
-
Real-world comparative outcomes of EGFR-TKIs for first-line treatment of EGFR+ metastatic non–small-cell lung cancer (2025)
-
Real-World Comparative Outcomes of Egfr-Tkis for First-Line Treatment of Metastatic Non–Small-Cell Lung Cancer (2024)
Collaboration Network
Top Collaborators
- Transcatheter Aortic Valve Replacement With the Evolut FX Self-Expanding Versus SAPIEN 3 Ultra Resilia Balloon-Expandable Valves
- Etiologies and Impact of Exclusion Rates for Transcatheter Mitral and Tricuspid Valve Structural Heart Clinical Trials at a High-Volume Quaternary Care Hospital
- Transcatheter Aortic Valve Embolization Complicated by Inversion and Left Ventricular Outflow Tract Obstruction
- Deformation of Surgically Implanted Aortic Valves: CT Findings Prior to Valve-in-Valve Implantation and Association With Mechanism of Failure
- Simplified and Improved Commissural Alignment Technique With the Supra-Annular, Self-Expanding Evolut FX System
- Transcatheter Aortic Valve Replacement With the Evolut FX Self-Expanding Versus SAPIEN 3 Ultra Resilia Balloon-Expandable Valves
- Etiologies and Impact of Exclusion Rates for Transcatheter Mitral and Tricuspid Valve Structural Heart Clinical Trials at a High-Volume Quaternary Care Hospital
- Transcatheter Aortic Valve Embolization Complicated by Inversion and Left Ventricular Outflow Tract Obstruction
- Deformation of Surgically Implanted Aortic Valves: CT Findings Prior to Valve-in-Valve Implantation and Association With Mechanism of Failure
- Simplified and Improved Commissural Alignment Technique With the Supra-Annular, Self-Expanding Evolut FX System
- Transcatheter Aortic Valve Replacement With the Evolut FX Self-Expanding Versus SAPIEN 3 Ultra Resilia Balloon-Expandable Valves
- Etiologies and Impact of Exclusion Rates for Transcatheter Mitral and Tricuspid Valve Structural Heart Clinical Trials at a High-Volume Quaternary Care Hospital
- Transcatheter Aortic Valve Embolization Complicated by Inversion and Left Ventricular Outflow Tract Obstruction
- Deformation of Surgically Implanted Aortic Valves: CT Findings Prior to Valve-in-Valve Implantation and Association With Mechanism of Failure
- Simplified and Improved Commissural Alignment Technique With the Supra-Annular, Self-Expanding Evolut FX System
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Editorial response to Cosentino and Marino RE: detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 specific antibodies in breastfeeding infant stool following mother’s COVID-19 vaccination
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Editorial response to Cosentino and Marino RE: detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 specific antibodies in breastfeeding infant stool following mother’s COVID-19 vaccination
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Editorial response to Cosentino and Marino RE: detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 specific antibodies in breastfeeding infant stool following mother’s COVID-19 vaccination
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Editorial response to Cosentino and Marino RE: detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 specific antibodies in breastfeeding infant stool following mother’s COVID-19 vaccination
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Editorial response to Cosentino and Marino RE: detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 specific antibodies in breastfeeding infant stool following mother’s COVID-19 vaccination
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Editorial response to Cosentino and Marino RE: detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 specific antibodies in breastfeeding infant stool following mother’s COVID-19 vaccination
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Editorial response to Cosentino and Marino RE: detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 specific antibodies in breastfeeding infant stool following mother’s COVID-19 vaccination
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Editorial response to Cosentino and Marino RE: detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 specific antibodies in breastfeeding infant stool following mother’s COVID-19 vaccination
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Editorial response to Cosentino and Marino RE: detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 specific antibodies in breastfeeding infant stool following mother’s COVID-19 vaccination
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Editorial response to Cosentino and Marino RE: detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 specific antibodies in breastfeeding infant stool following mother’s COVID-19 vaccination
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Editorial response to Cosentino and Marino RE: detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 specific antibodies in breastfeeding infant stool following mother’s COVID-19 vaccination
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Editorial response to Cosentino and Marino RE: detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
- Detection of SARS-CoV-2 specific antibodies in breastfeeding infant stool following mother’s COVID-19 vaccination
Similar Researchers
Based on overlapping research topics